Ventyx Biosciences (VTYX) Peer Comparison

$14.00

$0.00 (0.00%)

As on 06-Mar-2026 09:30EDT

Market cap

$1,005 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

5.2

Div. Yield

0 %

Edit

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Market cap ($ Mln)	1,005	1,680
Revenue ($ Mln)	1	--
Net Profit ($ Mln)	-106.61	-105.64
Net Margin (%)	-7,362.36	--
RoE (%)	-50.41	-64.15
Price to Earnings	--	--
Price-To-Book	5.25	11.05

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Operating Revenue	1.45	0.00
Cost of Revenue	0.68	0.20
Gross Profit	-1.35	-3.54
Operating Expenses	116.72	112.44
Operating Profit (EBIT)	-116.72	-112.64
Other Income	0.00	0.00
Profit before Tax	-106.61	-105.64
Provision for Tax	0.00	0.00
Profit after Tax (Net Income)	-106.61	-105.64
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Shareholder's Funds	191.36	151.98
Minority Interest	0.00	0.00
Non-Current Liabilities	8.84	0.39
Current Liabilities	11.26	13.38
Total Liabilities	276.56	240.33

Assets ($ Mln)

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Non-Current Assets	10.37	4.69
Current Assets	201.09	161.05
Total Assets	276.56	240.33
Total Debt*	10.02	2.60
Net Current Assets	189.84	147.67

Cashflow ($ Mln)

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Cash From Operating Activities	-130.87	-83.30
Cash Flow from Investing Activities	-15.51	52.70
Cash from Financing Activities	122.12	152.85
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
ROCE (%)	-51.84	-74.56
ROE (%)	-50.41	-64.15
ROA (%)	-39.77	-70.91
EBIT Margin (%)	-7,919.68	--
Net Margin (%)	-7,362.36	--
Cash Profit Margin (%)	-0.01	--

Growth Ratios

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Revenue Growth (%)	34.57	--
EBIT Growth (%)	31.07	5.14
Net Profit Growth (%)	30.10	1.73
EPS Growth (%)	36.65	50.23
Book Value Growth (%)	-31.97	-71.30

Valuation Ratios

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Price / Earnings	-1.15	-0.07
Price / Book Value	0.61	0.05
Dividend Yield (%)	--	--
EV/EBITDA	0.35	1.61
Market Cap ($ Cr)	--	--

Solvency Ratios

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.01	0.01
Current Ratio	17.86	12.04
Quick Ratio	17.86	12.04
Interest Coverage	--	--

Operating Efficiency Ratios

	Ventyx Biosciences (VTYX)	RAPT Therapeutics (RAPT)
Debtors to sales (%)	34.53	--
Asset Turnover	0.01	0.00
Receivable days	--	--
Inventory Days	-216.77	--
Payable days	1,203.86	332.89
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly